Dendreon Corp.

Click Here To EMAIL INQUIRY
Web: http://www.dendreon.com
E-Mail:
Address: 3005 First Avenue, Seattle, Washington 98121, USA
Phone: +1-(206)-256-4545, 866-477-6782 | Fax: +1-(206)-256-0571 | Map/Directions >>

Profile: Dendreon Corp. develops innovative cancer therapies. We focus on targeting cancer to transform lives through the discovery, development and commercialization of novel therapeutics to fight cancer. We produce active cellular immunotherapy product candidates designed to stimulate an immune response. We develop an orally-available small molecule targeting TRPM8, that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. We also focus on bringing new cancer treatments to patients. We strive to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile.

The company was founded in 1992, has revenues of < USD 1 Million, has ~210 employees.

2 Products/Services (Click for related suppliers)

• Hematopoietic Stem Cell Concentration System (FDA Code: MZJ)

• Lymphocyte Separation Medium (FDA Code: JCF / 864.8500)

A lymphocyte separation medium is a device used to isolate lymphocytes from whole blood.